P
Prelude Therapeutics (PRLD)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Prelude Therapeutics (PRLD)
Prelude Therapeutics Inc. is a clinical-stage precision oncology company. The Company is focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers. Its drug discovery engine is designed to... Read more
- USD3.87
- USD4.13
- USD3.87
- USD6.89
- -17.70%
- --
- 44.05k
- 204M
- 1.66
- -38.70%
Stock News
22 minutes ago
Kopin Achieves Important Technical Milestones in Development of NeuralDisplay™ Architecture
Yahoo
47 minutes ago
Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals
Yahoo
52 minutes ago
KKR to Acquire $1.64 Billion Student Housing Portfolio from BREIT
Yahoo
52 minutes ago
Suburban Propane Partners, L.P. Declares Quarterly Distribution of $0.325 per Common Unit
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
